ORIGIN
Commercial- Indications
- Knee joint replacement
Company intelligence / Profile preview
Symbios Orthopédie is a Swiss leader in the design, manufacture, and marketing of individualized orthopedic implants for hip and knee replacements. The company has over 30 years of experience pioneering custom implant manufacturing technology. Its products are fully commercialized and widely used in Europe and other markets. In April 2024, the company voluntarily suspended sales of its ORIGIN® Posterior Stabilised Patient-Matched Total Knee Replacement device in the UK due to higher revision rates observed with this specific product variant; no increased risk was found with other variants or products[9].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Symbios Orthopédie.